The Hidden Struggle of Pure O OCD and Invisible Compulsions

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Pure O is an informal term people use for OCD that seems to involve only obsessions, but the clinical picture usually still includes compulsions. Those compulsions are often mental acts such as counting, reviewing memories, praying silently, checking your feelings, or trying to reason your way to certainty. OCD itself is defined by obsessions, compulsions, or both, and official psychiatric guidance includes mental acts within the definition of compulsions.

That means a person can look calm on the outside while doing hours of ritual work in private. The struggle stays hidden because there may be little or no visible washing, checking, arranging, or repeating. Instead, the disorder runs through internal loops that keep pulling you back into fear, doubt and short bursts of relief. Mental compulsions can fly under the radar precisely because other people cannot see them happening.

This hidden form of OCD often centers on themes that feel deeply personal. Intrusive thoughts may involve harm, sex, religion, morality, identity, relationships, health, or the fear that you missed some important fact. The content can feel shocking, but the common thread is the same. The thought feels urgent, unwanted and hard to leave alone, and you feel driven to do something mental to settle it.

Common mental rituals like counting and reviewing memories

Mental compulsions are repetitive internal acts used to reduce distress or prevent a feared outcome. Official clinical guidance lists counting and silently repeating words as examples. Broader psychiatric guidance also describes compulsions as mental acts performed in response to an obsession, with temporary relief followed by a stronger pull to do the same thing again later.

One common ritual is mental reviewing. You may replay a conversation again and again to check if you sounded cruel, dishonest, flirtatious, blasphemous, unsafe, or careless. You may revisit a drive to see if you hit someone, replay an encounter to see if you offended a stranger, or go over a private thought to decide what it “really” means. This kind of internal back and forth has been described as a compulsive reasoning pattern aimed at relieving anxiety and resolving uncertainty.

Another common ritual is counting. You may count breaths, steps, taps, prayers, or repeated thoughts until the number feels correct. The counting can be linked to a fear that something bad will happen if the sequence stays unfinished, or it can be tied to a “just right” feeling that creates tension until the count lands on the right number. Because this happens in your head, people around you may have no idea how much time it takes.

Silent reassurance is another major pattern. You may ask yourself the same question over and over and try to answer it with logic. You may tell yourself you are safe, that you would know if you meant harm, that the relationship is fine, or that the thought does not match your values. For a moment, that reasoning can lower distress. Then the doubt returns and asks for another round. Internal debate becomes a ritual when its real function is to bring quick relief rather than solve a real problem.

Thought neutralizing can also become a hidden compulsion. Some people try to “cancel” a feared thought with a good thought, a prayer, a phrase, or a mental image. Others scan their body to test for arousal, fear, guilt, attraction, or certainty. Others mentally check their motives to prove they are still a good person. These patterns are easy to confuse with ordinary self reflection, but in OCD they are rigid, repetitive and distress driven.

Suppression can join the same cycle. You may try to force the thought away, replace it with something pure or safe, or stop yourself from thinking about the topic at all. That attempt often gives the thought even more status in your mind. The result is a day shaped by constant self monitoring and repeated internal correction.

The exhaustion of fighting your own mind all day

Pure O can be draining because the battle happens inside your attention all day long. You may look quiet in a meeting, at dinner, in class, or while driving, yet inside you are replaying, checking, canceling, counting, or debating. That constant inner labor can consume hours and leave you mentally worn down even when nothing visible has happened. Official guidance notes that OCD symptoms can be time consuming, often take more than an hour a day and can interfere with daily life.

The exhaustion is not only mental. Sleep can get worse when the mind keeps reviewing events after the day ends. Work and school can suffer because concentration keeps getting pulled back into a ritual loop. Relationships can strain when you seem distant, preoccupied, or stuck in repeated conversations about the same fear. Psychiatric guidance states that OCD can significantly interfere with social interactions and normal routine, and severe ritual repetition can fill the day.

Shame adds another layer. Many people with internalized symptoms hide them because the thoughts feel taboo or frightening. You may fear that saying them out loud will make other people misread you. You may also fear judgment from a clinician or loved one. Official guidance notes that diagnosis can be difficult because people may not tell a health care provider about their obsessions and compulsions out of fear of judgment.

This can create a very lonely pattern. You may feel trapped in a private courtroom where every thought is treated like evidence and every moment of uncertainty feels dangerous. Because the rituals are mental, other people may tell you to “stop thinking about it” without seeing that the thinking itself has become the compulsion. That kind of misunderstanding can make symptoms stay hidden for years.

Stress often makes the loop louder. Official guidance states that symptoms may worsen during times of stress, and a person’s obsessions and compulsions may change over time. In Pure O presentations, that can mean old themes fade and new ones take over while the same internal ritual style keeps running underneath.

Why standard therapy sometimes misses these symptoms

Pure O can be missed when treatment focuses only on visible behavior. If a clinician asks only about handwashing, checking doors, arranging objects, or repeating tasks, the person may say no and the hidden rituals stay undisclosed. That can lead to the false idea that the problem is only overthinking, generalized anxiety, guilt, or depression. Diagnostic guidance states that OCD can be hard to diagnose because symptoms can overlap with worry, anxiety and low mood.

Another reason it gets missed is that mental compulsions can sound reasonable when described casually. Reviewing an event can sound like caution. Repeating a prayer can sound like faith practice. Searching for the “real meaning” of a thought can sound like honest self examination. In OCD, the clue is the function. The act is repeated to lower distress or resolve uncertainty, and the relief fades fast.

Treatment can also stall when talk therapy turns into more rumination. If you spend session after session analyzing the content of the obsession in search of certainty, the therapy can accidentally feed the same loop that keeps you stuck. The hidden ritual is then happening inside treatment instead of outside it. That is one reason accurate identification of mental compulsions matters so much.

The most established psychotherapy for OCD is exposure and response prevention. That approach asks you to face the obsessional trigger and resist the compulsion that usually follows. In Pure O, response prevention often means not reviewing the memory again, not checking your feelings, not counting, not silently neutralizing and not trying to reason your way to total certainty. Treatment also commonly includes medication, psychotherapy, or both.

A practical shift can start with naming the internal act correctly. If you notice that you are replaying, debating, testing, scanning, canceling, or silently reassuring yourself for relief, that is a sign you may be inside a compulsion rather than solving a real issue. That distinction does not make the fear vanish. It gives you a cleaner way to spot the cycle and to stop feeding it.

Pure O can feel invisible, but it is still OCD. The absence of obvious physical rituals does not make the condition milder or less impairing. Hidden compulsions can take up just as much time, create just as much distress and interfere with life just as sharply as visible rituals.

Conclusion

Conditions built around internal suffering deserve the same scientific focus as those with outward signs, and we at Rose Hill Life Sciences are a psychedelic research organization specializing in the production and research of Psilocybe cubensis, operating at the intersection of science and therapeutic integration, and are based in Massachusetts.




Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.